In ASCVD, 81 mg and 325 mg of aspirin did not differ for CV or bleeding events
- PMID: 34606309
- DOI: 10.7326/ACPJ202110190-118
In ASCVD, 81 mg and 325 mg of aspirin did not differ for CV or bleeding events
Abstract
Jones WS, Mulder H, Wruck LM, et al. Comparative effectiveness of aspirin dosing in cardiovascular disease. N Engl J Med. 2021;384:1981-90. 33999548.
Comment on
-
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.N Engl J Med. 2021 May 27;384(21):1981-1990. doi: 10.1056/NEJMoa2102137. Epub 2021 May 15. N Engl J Med. 2021. PMID: 33999548 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources